Preoperative antiseptics in clean/contaminated maxillofacial and oral surgery: prospective randomized study von Kosutic, D, Uglesic, V, Perkovic, D, Persic, Z, Solman, L, Lupi-Ferandin, S, Knezevic, P, Sokler, K, Knezevic, G

Volltext

New classification of the styloid process length--clinical application on the biological base von Sokler, K, Sandev, S

Volltext

Evaluation of sporadic cases of odontogenic keratocysts in multicentric study von Valter, K, Pavelić, B, Katanec, D, Sokler, K, Galić, N, Segović, S, Donath, K, Herman, R

Volltext

Calcifying odontogenic cyst--Gorlin's cyst--report of two cases von Knezević, Goran, Sokler, Klara, Kobler, Pavel, Manojlović, Spomenka

Volltext

New Classification of the Styloid Process Length – Clinical Application on the Biological Base von Sokler, K, Sandev, S

Volltext

Mass Media Health Communication Campaigns Combined with Health-Related Product Distribution: A Community Guide Systematic Review von ROBINSON, Maren N, TANSIL, Kristin A, SOKLER, Lynn A, GREEN, Lawrence W, MILLER, Therese, DEARING, James W, EVANS, William D, SNYDER, Leslie B, VISWANATH, K. Kasisomayajula, BEISTLE, Diane M, CHERVIN, Doryn D, BERNHARDT, Jay M, ELDER, Randy W, RIMER, Barbara K, SOLER, Robin E, LABRE, Magdala P, MERCER, Shawna L, EROGLU, Dogan, BAUR, Cynthia, LYON-DANIEL, Katherine, FRIDINGER, Fred

Volltext

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): a... von Eichhorst, Barbara, Dr, Fink, Anna-Maria, MD, Bahlo, Jasmin, PhD, Busch, Raymonde, Dipl Math, Kovacs, Gabor, MD, Maurer, Christian, MD, Lange, Elisabeth, MD, Köppler, Hubert, Prof, Kiehl, Michael, Prof, Sökler, Martin, MD, Schlag, Rudolf, MD, Vehling-Kaiser, Ursula, MD, Köchling, Georg, MD, Plöger, Christoph, MD, Gregor, Michael, MD, Plesner, Torben, MD, Trneny, Marek, Prof, Fischer, Kirsten, MD, Döhner, Harmut, Prof, Kneba, Michael, Prof, Wendtner, Clemens-Martin, Prof, Klapper, Wolfram, Prof, Kreuzer, Karl-Anton, Prof, Stilgenbauer, Stephan, Prof, Böttcher, Sebastian, MD, Hallek, Michael, Prof

Volltext

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial von Borchmann, Peter, Plütschow, Annette, Kobe, Carsten, Greil, Richard, Meissner, Julia, Topp, Max S, Ostermann, Helmut, Dierlamm, Judith, Mohm, Johannes, Thiemer, Julia, Sökler, Martin, Kerkhoff, Andrea, Ahlborn, Miriam, Halbsguth, Teresa V, Martin, Sonja, Keller, Ulrich, Balabanov, Stefan, Pabst, Thomas, Vogelhuber, Martin, Hüttmann, Andreas, Wilhelm, Martin, Zijlstra, Josée M, Moccia, Alden, Kuhnert, Georg, Bröckelmann, Paul J, von Tresckow, Bastian, Fuchs, Michael, Klimm, Beate, Rosenwald, Andreas, Eich, Hans, Baues, Christian, Marnitz, Simone, Hallek, Michael, Diehl, Volker, Dietlein, Markus, Engert, Andreas

Volltext

Mass Media Health Communication Campaigns Combined with Health-Related Product Distribution von Robinson, Maren N., MPH, Tansil, Kristin A., MSW, Elder, Randy W., PhD, MEd, Soler, Robin E., PhD, Labre, Magdala P., PhD, Mercer, Shawna L., MSc, PhD, Eroglu, Dogan, PhD, Baur, Cynthia, PhD, Lyon-Daniel, Katherine, PhD, Fridinger, Fred, DrPH, Sokler, Lynn A., BS, Green, Lawrence W., DrPH, Miller, Therese, DrPH, Dearing, James W., PhD, Evans, William D., PhD, Snyder, Leslie B., PhD, Kasisomayajula Viswanath, K., PhD, Beistle, Diane M., BA, Chervin, Doryn D., DrPH, DSc, Bernhardt, Jay M., PhD, MPH, Rimer, Barbara K., DrPH

Volltext

Action, Not Talk: A Simulation of Risk Communication During the First Hours of a Pandemic von Freimuth, Vicki S., Hilyard, Karen M., Barge, J. Kevin, Sokler, Lynn A.

Volltext

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Gr... von Eichenauer, Dennis A, Plütschow, Annette, Kreissl, Stefanie, Sökler, Martin, Hellmuth, Johannes C, Meissner, Julia, Mathas, Stephan, Topp, Max S, Behringer, Karolin, Klapper, Wolfram, Kuhnert, Georg, Dietlein, Markus, Kobe, Carsten, Fuchs, Michael, Diehl, Volker, Engert, Andreas, Borchmann, Peter

Volltext

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma von Engert, Andreas, Plütschow, Annette, Eich, Hans Theodor, Lohri, Andreas, Dörken, Bernd, Borchmann, Peter, Berger, Bernhard, Greil, Richard, Willborn, Kay C, Wilhelm, Martin, Debus, Jürgen, Eble, Michael J, Sökler, Martin, Ho, Antony, Rank, Andreas, Ganser, Arnold, Trümper, Lorenz, Bokemeyer, Carsten, Kirchner, Hartmut, Schubert, Jörg, Král, Zdenek, Fuchs, Michael, Müller-Hermelink, Hans-Konrad, Müller, Rolf-Peter, Diehl, Volker

Volltext

Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group von Kreissl, Stefanie, Müller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Sökler, Martin, Markova, Jana, Bernhard, Jürg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rüffer, Jens-Ulrich, Flechtner, Hans-Henning, Möstl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker, Borchmann, Peter

Volltext

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the... von Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Plütschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Sökler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter, Eichenauer, Dennis A.

Volltext

FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior do... von Lorenzen, Sylvie, Thuss-Patience, Peter, Pauligk, Claudia, Gökkurt, Eray, Ettrich, Thomas, Lordick, Florian, Stahl, Michael, Reichardt, Peter, Sökler, Martin, Pink, Daniel, Probst, Stefan, Hinke, Axel, Goetze, Thorsten O., Al-Batran, Salah E.

Volltext

Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies von Akbil, Bengisu, Meyer, Tim, Stubbemann, Paula, Thibeault, Charlotte, Staudacher, Olga, Niemeyer, Daniela, Jansen, Jenny, Mühlemann, Barbara, Doehn, Jan, Tabeling, Christoph, Nusshag, Christian, Hirzel, Cédric, Sanchez, David Sökler, Nieters, Alexandra, Lother, Achim, Duerschmied, Daniel, Schallner, Nils, Lieberum, Jan Nikolaus, August, Dietrich, Rieg, Siegbert, Falcone, Valeria, Hengel, Hartmut, Kölsch, Uwe, Unterwalder, Nadine, Hübner, Ralf-Harto, Jones, Terry C., Suttorp, Norbert, Drosten, Christian, Warnatz, Klaus, Spinetti, Thibaud, Schefold, Joerg C., Dörner, Thomas, Sander, Leif Erik, Corman, Victor M., Merle, Uta, Kurth, Florian, von Bernuth, Horst, Meisel, Christian, Goffinet, Christine

Volltext

Long Term Follow‐up Data and Health‐Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG) von Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Franklin, Jeremy, Zhang, Can, Maurer, Christian, De Silva, Nisha, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Sökler, Martin, Schlag, Rudolf, Vehling‐Kaiser, Ursula, Köchling, Georg, Plöger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Döhner, Hartmut, Kneba, Michael, Wendtner, Clemens‐Martin, Klapper, Wolfram, Kreuzer, Karl‐Anton, Böttcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria, Hallek, Michael, Eichhorst, Barbara

Volltext

The role of trephine bone marrow biopsies in the era of measurable residual disease—Results from the CLL10 trial of the German CLL Study Group (GCLLSG) von Kutsch, Nadine, Robrecht, Sandra, Fink, Anna, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Sökler, Martin, Schlag, Rudolf, Vehling‐Kaiser, Ursula, Köchling, Georg, Plöger, Christoph, Gregor, Michael, Plesner, Torben, Clausen, Michael R., Oschlies, Ilske, Ritgen, Matthias, Herling, Marco, Fischer, Kirsten, Döhner, Hartmut, Wendtner, Clemens‐Martin, Kreuzer, Karl‐Anton, Stilgenbauer, Stephan, Hallek, Michael, Böttcher, Sebastian, Klapper, Wolfram, Eichhorst, Barbara

Volltext

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial von Böll, Boris, Plütschow, Annette, Bürkle, Carolin, Atta, Johannes, Pfreundschuh, Michael, Feuring‐Buske, Michaela, Vogelhuber, Martin, Sökler, Martin, Eichenauer, Dennis A., Thielen, Indra, Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter

Volltext

Sustained complete remission of recurrent acute myeloid leukaemia with a single dose of gemtuzumab ozogamicin and low-dose interleukin-2 maintenance von Radsak, M P, Salih, H R, Sökler, M, Kanz, L, Denzlinger, C

Volltext